Drug information provided by: Merative, Micromedex®
Avelumab injection is used to treat a kind of skin cancer called Merkel cell carcinoma (MCC) that has spread.
Avelumab injection is also used to treat urothelial carcinoma (a type of urinary tract cancer), that has spread throughout the body (metastatic) or cannot be removed by surgery (advanced). This medicine is given to patients who have received other cancer medicines (eg, platinum) that did not work well. It is also used as first-line maintenance treatment with urothelial carcinoma that has spread in patients who have responded well with platinum-containing cancer medicines.
Avelumab injection is also used in combination with other medicines (eg, axitinib) as first-line treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer.
Avelumab belongs to the group of medicines called antineoplastics. It helps change the immune system to help control the growth of cancer cells.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Nov. 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Join our Year-End Challenge and triple your gift to help shape the future of healthcare!